PT930877E - D-metionina para reduzir a toxicidade de compostos antitumorais contendo platina - Google Patents

D-metionina para reduzir a toxicidade de compostos antitumorais contendo platina

Info

Publication number
PT930877E
PT930877E PT97911634T PT97911634T PT930877E PT 930877 E PT930877 E PT 930877E PT 97911634 T PT97911634 T PT 97911634T PT 97911634 T PT97911634 T PT 97911634T PT 930877 E PT930877 E PT 930877E
Authority
PT
Portugal
Prior art keywords
methionine
toxicity
reduce
platinum
compounds containing
Prior art date
Application number
PT97911634T
Other languages
English (en)
Inventor
Kathleen C M Campbell
Original Assignee
Univ Southern Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern Illinois filed Critical Univ Southern Illinois
Publication of PT930877E publication Critical patent/PT930877E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97911634T 1996-10-03 1997-10-02 D-metionina para reduzir a toxicidade de compostos antitumorais contendo platina PT930877E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2775096P 1996-10-03 1996-10-03

Publications (1)

Publication Number Publication Date
PT930877E true PT930877E (pt) 2006-09-29

Family

ID=21839569

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97911634T PT930877E (pt) 1996-10-03 1997-10-02 D-metionina para reduzir a toxicidade de compostos antitumorais contendo platina

Country Status (10)

Country Link
EP (1) EP0930877B1 (pt)
JP (1) JP4260889B2 (pt)
AT (1) ATE323475T1 (pt)
AU (1) AU726392B2 (pt)
CA (1) CA2265983C (pt)
DE (1) DE69735722T2 (pt)
DK (1) DK0930877T3 (pt)
ES (1) ES2263172T3 (pt)
PT (1) PT930877E (pt)
WO (1) WO1998014182A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071230B2 (en) 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
CA2461219A1 (en) * 2001-09-24 2003-04-03 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
USRE48077E1 (en) 2013-02-28 2020-07-07 Anida Pharma Inc. Methods of treating ototoxicity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192109A (ja) * 1992-09-04 1994-07-12 Fuji Kagaku Kogyo Kk 抗腫瘍効果増強剤

Also Published As

Publication number Publication date
JP4260889B2 (ja) 2009-04-30
ATE323475T1 (de) 2006-05-15
AU4895797A (en) 1998-04-24
DE69735722D1 (de) 2006-05-24
DE69735722T2 (de) 2007-04-12
DK0930877T3 (da) 2006-08-21
AU726392B2 (en) 2000-11-09
EP0930877A1 (en) 1999-07-28
CA2265983A1 (en) 1998-04-09
WO1998014182A1 (en) 1998-04-09
JP2001501626A (ja) 2001-02-06
CA2265983C (en) 2003-12-23
ES2263172T3 (es) 2006-12-01
EP0930877B1 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
DE69815872D1 (de) Verwendung von d-methionin zur verminderung der toxizität von ototoxischen arzneimitteln und geräusch
CA2294247A1 (en) Antioxidant enhancement of therapy for hyperproliferative conditions
CY2473B1 (en) New phenanthridines.
EP1478406A4 (en) COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS AND OTHER MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF
DK0612248T3 (da) Præparat, der indeholder cisplatin og topotecan som antitumormiddel
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
TR199903214T2 (xx) Bir antit�m�r maddesi ve bir hidroksimik asit t�revini ihtiva eden, antit�m�r etkinli�i artt�r�lm�� ve yan etkileri d���r�lm�� farmas�tik bile�im.
EP0211354A3 (en) Nucleosides and their use as antineoplastic agents
TR199901904T2 (xx) 3-piridil enantiyomerleri ve bunlar�n analjezik olarak kullan�lmas�.
IL133824A0 (en) Tetrazole derivatives, medicaments containing same and use thereof
EP0902789A4 (pt)
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
MX9400434A (es) Potenciamiento de temozolomida en celulas de tumores humanos.
EP2020237A3 (en) Ceramide and chemotherapeutic agents for inducing cell death
DK1161228T3 (da) Præparat omfattende isoquercetin og ascorbinsyre i en sustained release-form
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
WO2005039554A3 (en) Therapeutic use of methionine for the treatment or prevention of mucositis
DK0930877T3 (da) D-methionin til formindskelse af toksiciteten af platinholdige antitumorforbindelser
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
MX9700359A (es) Derivados terpenoides utiles como agentes antitumorales.
CA2458856A1 (en) Improved therapeutic protocols
ES2105959A1 (es) Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion.
GB9710698D0 (en) Composition
MX9701606A (es) Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno.
DE60203895D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie